Amyloid structures: much more than just a cross-β fold.

[1]  Jennifer C. Lee,et al.  Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease Related C-Terminal Truncations. , 2019, Journal of molecular biology.

[2]  Liang Zhao,et al.  The Hsp70 Chaperone System Stabilizes a Thermo-sensitive Subproteome in E. coli. , 2019, Cell reports.

[3]  J. Cox,et al.  The nucleolus functions as a phase-separated protein quality control compartment , 2019, Science.

[4]  M. Diamond,et al.  Propagation of Protein Aggregation in Neurodegenerative Diseases. , 2019, Annual review of biochemistry.

[5]  S. Radford,et al.  Molecular insights into the surface-catalyzed secondary nucleation of amyloid-β40 (Aβ40) by the peptide fragment Aβ16–22 , 2019, Science Advances.

[6]  D. Eisenberg,et al.  Cryo-EM Structures of Four Polymorphic TDP-43 Amyloid Cores , 2019, bioRxiv.

[7]  M. Bolognesi,et al.  Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient , 2019, Nature Communications.

[8]  A. Murzin,et al.  Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules , 2019, Nature.

[9]  M. Fändrich,et al.  Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis , 2019, Nature Communications.

[10]  N. Grigorieff,et al.  Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids , 2019, Nature Communications.

[11]  C. Dobson,et al.  Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes , 2019, Nature Communications.

[12]  J. Freed,et al.  Cofactors are essential constituents of stable and seeding-active tau fibrils , 2018, Proceedings of the National Academy of Sciences.

[13]  N. Cairns,et al.  Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics , 2018, The Journal of Biological Chemistry.

[14]  A. Murzin,et al.  Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases , 2018, bioRxiv.

[15]  S. Radford,et al.  The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism , 2018, Nature Communications.

[16]  R. Jelinek,et al.  Vesicle-Based Assays to Study Membrane Interactions of Amyloid Peptides. , 2018, Methods in molecular biology.

[17]  M. P. Jackson,et al.  A new era for understanding amyloid structures and disease , 2018, Nature Reviews Molecular Cell Biology.

[18]  A. Murzin,et al.  Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold , 2018, bioRxiv.

[19]  D. Eisenberg,et al.  Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel , 2018, Alzheimer's & Dementia.

[20]  S. Linse,et al.  Secondary nucleation in amyloid formation. , 2018, Chemical communications.

[21]  Xueming Li,et al.  Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy , 2018, Cell Research.

[22]  A. Šarić,et al.  Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation. , 2018, Annual review of physical chemistry.

[23]  Alexey G. Murzin,et al.  Structures of filaments from Pick’s disease reveal a novel tau protein fold , 2018, Nature.

[24]  A. Miranker,et al.  Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid , 2018, Nature Communications.

[25]  R. Riek,et al.  Cryo-EM structure of alpha-synuclein fibrils , 2018, bioRxiv.

[26]  B. Reif,et al.  Physical basis of amyloid fibril polymorphism , 2018, Nature Communications.

[27]  W. Baumeister,et al.  In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment , 2018, Cell.

[28]  Conrad C. Huang,et al.  UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.

[29]  Martin H. Schaefer,et al.  Spatiotemporal Proteomic Profiling of Huntington’s Disease Inclusions Reveals Widespread Loss of Protein Function , 2017, Cell reports.

[30]  Nick C Fox,et al.  Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[31]  G. Schröder,et al.  Fibril structure of amyloid-β(1–42) by cryo–electron microscopy , 2017, Science.

[32]  Wolfgang Baumeister,et al.  In Situ Architecture and Cellular Interactions of PolyQ Inclusions , 2017, Cell.

[33]  S. Radford,et al.  Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils , 2017, Journal of molecular biology.

[34]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[35]  S. Radford,et al.  Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation , 2017, Biophysical Reviews.

[36]  Michele Vendruscolo,et al.  Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method , 2017, Science Advances.

[37]  M. Hoshino.  Fibril formation from the amyloid-β peptide is governed by a dynamic equilibrium involving association and dissociation of the monomer , 2016, Biophysical Reviews.

[38]  M. G. Savelieff,et al.  Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors. , 2017, Chemical Society reviews.

[39]  John Collinge,et al.  Structural Variation in Amyloid-β Fibrils from Alzheimer’s Disease Clinical Subtypes , 2016, Nature.

[40]  C. Dobson,et al.  Structural basis of synaptic vesicle assembly promoted by α-synuclein , 2016, Nature Communications.

[41]  Peter Güntert,et al.  Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril , 2016, Proceedings of the National Academy of Sciences.

[42]  Charles D. Schwieters,et al.  Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.

[43]  Michael R. Holden,et al.  RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth , 2015, Biochemistry.

[44]  S. Radford,et al.  Mechanisms of amyloid formation revealed by solution NMR , 2015, Progress in nuclear magnetic resonance spectroscopy.

[45]  Michael T. Colvin,et al.  High Resolution Structural Characterization of Aβ42 Amyloid Fibrils by Magic Angle Spinning NMR , 2015, Journal of the American Chemical Society.

[46]  S. Radford,et al.  pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers , 2015, Proceedings of the National Academy of Sciences.

[47]  G. Irace,et al.  The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity , 2015, Molecules.

[48]  Guojun Bu,et al.  ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners? , 2014, Neuron.

[49]  Michele Vendruscolo,et al.  Atomic structure and hierarchical assembly of a cross-β amyloid fibril , 2013, Proceedings of the National Academy of Sciences.

[50]  J. H. Viles,et al.  Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases , 2012 .

[51]  D. Frenkel,et al.  Intrinsic disorder modulates protein self-assembly and aggregation , 2012, Proceedings of the National Academy of Sciences.

[52]  Michele Vendruscolo,et al.  Metastability of native proteins and the phenomenon of amyloid formation. , 2011, Journal of the American Chemical Society.

[53]  Jörg Gsponer,et al.  Intrinsically disordered proteins: regulation and disease. , 2011, Current opinion in structural biology.

[54]  Vincent A Voelz,et al.  Taming the complexity of protein folding. , 2011, Current opinion in structural biology.

[55]  J. Samitier,et al.  Modulation of Aβ42 fìbrillogenesis by glycosaminoglycan structure , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Tuomas P. J. Knowles,et al.  An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.

[57]  N. Grigorieff,et al.  Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. , 2009, Journal of molecular biology.

[58]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[59]  Michele Vendruscolo,et al.  Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils , 2007, Science.

[60]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[61]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[62]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[63]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[64]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[65]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Leapman,et al.  Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. , 2002, Biochemistry.

[67]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[68]  L. Serpell,et al.  Molecular Structure of a Fibrillar Alzheimer's Aβ Fragment† , 2000 .

[69]  Louise C. Serpell,et al.  Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix , 1996 .

[70]  Cyrus Chothia,et al.  Conformation of twisted β-pleated sheets in proteins , 1973 .

[71]  E. Atkins,et al.  “Cross-β” conformation in proteins☆ , 1968 .

[72]  J. Trojanowski,et al.  Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review , 2019, JAMA neurology.

[73]  L. Serpell,et al.  Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. , 1996, Structure.